派
02565
派格生物醫藥－Ｂ
11.190
-2.540-18.50%Closed16:09 05/15 HKT
OPEN/PREV CLOSE--/11.190
TODAY RANGE-
VOL0
MARKET CAP7.28B
52 WEEK RANGE8.680-77.000
AVG VOL (3M)1.92M
% TURNOVER0%
TURNOVER0
P/E (TTM)-31.548
% RANGE--
EPS(TTM)-0.590
P/E(FORWARD)-42.295
P/B14.658
BVPS1.270
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.29B
SHARES OUTSTANDING391.09M
NEXT EARNINGS--
FREE FLOAT284.30M
LOT SIZE50
EX-DATE--
News
Press Releases
Financial Reports
Profile
PUBT·04/28 13:52
Pegbio publishes 2025 annual report
Reuters·03/23 08:31
PegBio Wins China Approval for PB-119 Vepinetide Injection###
Reuters·03/11 08:30
PegBio schedules board meeting to approve 2025 annual results
Reuters·12/22/2025 12:54
PegBio Raises HK$300 Million Through Placement of New H Shares
Reuters·11/14/2025 08:36
PegBio Wins China NMPA Approval for PB-119 Diabetes Drug
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.